Generic Drug Price Antitrust Litigation Expanded in Pennsylvania Court

The Eastern District of Pennsylvania has become the hub for the Generic Drug Price Fixing Antitrust Litigation. On April 7, the U.S. Judicial Panel on Multidistrict Litigation transferred several additional cases to the MDL that is pending in the Eastern District of Pennsylvania Court, expanding the scope of the litigation to include any actions related to the alleged price-fixing of … Read More

Xarelto Makers Want Information on Plaintiffs’ Litigation Funding

Xarelto

Bayer and Janssen Pharmaceuticals, the defendants in the Xarelto mass tort litigation, filed a motion last week asking for information about the financing of Xarelto lawsuits that may be selected for bellwether trials. Specifically, the Janssen and Bayer are seeking information regarding whether any of these cases are being financed by third parties, and if so, who is providing the … Read More

General Motors Ignition Switch Lawsuit Update

Our firm represents many individuals who were affected by the General Motors ignition switch recall and there are hundreds of individuals around the country who are awaiting resolution of the GM Multi District Litigation (MDL) Lawsuit currently underway in front of New York Judge Jesse Furman. We will provide ongoing updates on the status of the General Motors Ignition Switch … Read More

Johnson & Johnson Mired in Legal Troubles

Johnson and Johnson

Johnson & Johnson, one of the largest healthcare product manufacturers in the world, has been forced to defend itself against numerous product defect claims in recent years. Some have stemmed from products being defectively designed, and others have arisen from Johnson & Johnson’s failure to adequately warn customers of the potential risks of its products. Talcum Powder Products For decades, … Read More

Dianne Nast Named Co-Lead Counsel in Major Antitrust Litigation

Dianne Nast, founder of NastLaw, was named as co-lead counsel in the Generic Digoxin and Doxycycline Antitrust Litigation. Roberta Liebenberg of Fine, Kaplan, and Black was appointed as co-lead counsel alongside Ms. Nast. The appointment is being hailed as a major advancement in diversity, as this is one of the only known instances of two women being appointed to lead a … Read More

FDA Recalls

If the FDA identifies a violation of the law it is entrusted to enforce, the agency may take action in the interest of public safety. One way the agency protects consumers from unsafe drugs and medical devices post-approval is through an FDA recall. Drug companies and device manufacturers often go along with FDA recalls voluntarily. In some cases, however, they … Read More

NastLaw Ranked as Top 25 Mass Tort Law Firm

Top 25 Mass Tort Trial Lawyers

NastLaw was recognized as a Top 25 Mass Tort Law firm by The National Trial Lawyers. The National Trial Lawyers is a professional organization composed of the premier trial lawyers from across the country. The organization’s members exemplify superior qualifications as civil plaintiff or criminal defense trial lawyers. The organization provides continuing education for trial lawyers and provides recognition to … Read More

The FDA Approval Process

Food and Drug Administration (FDA)

The road toward Food and Drug Administration (FDA) approval begins long before the agency actually gets involved. The pharmaceutical company starts with its own laboratory research and animal trials. Later, it takes the first formal step in the FDA’s pharmaceutical approval process by submitting an investigational new drug (IND) application. The medical device approval process follows a similar path. The … Read More

Daniel Gallucci to Co-Chair Invokana Lawsuit Conference

Daniel Gallucci of NastLaw will be co-chairing the HarrisMartin MDL conference on November 30 in Charlotte, NC. The conference will cover the following litigation: Invokana Proton Pump Inhibitors Talcum Powder Xarelto Neil D. Overholtz of Aylstock, Witkin, Kreis & Overholtz, Michael M. Weinkowitz of Levin, Fishbein, Sedran & Berman, and Jeffrey S. Grand of Seeger Weiss will be co-chairing the … Read More

About the FDA

Food and Drug Administration (FDA)

What is the FDA? The Food and Drug Administration (FDA) is a federal agency within the U.S. Department of Health and Human Services. The FDA has broad regulatory authority over not just food and drugs, but also biologics such as vaccines, medical devices, tobacco products, certain cosmetics, and some veterinary products. The agency was formed in 1906 and today employs … Read More